Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardioprotective Effect of Metformin on microRNAs in Type 1 Diabetes Patients
IRCT20200217046520N1Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of metformin in diabetes mellitus type 1 (T1D) and cardiac morbidity, sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Change in plasma level of miR-222, Change in plasma level of miR-195 and 1 more. Started May 2020; status: completed.
02
Drugs
metformin
03
Conditions
diabetes mellitus type 1 (T1D)cardiac morbidity
Beyond the preview
Go deeper on IRCT20200217046520N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200217046520N1.